Live Vaccines Market to Outshine with High Growth; to Cross USD 24.15 BN by 2026

Posted On April 29, 2020     

The Global Live Vaccines Market report evaluates the market revenue to reach USD 24.15 BN mark in 2026. It was valued at USD at USD 16.06 BN in the year 2019. The CAGR is expected to be close to 6% from 2020 till the end of 2026 according to the newly published report by Value Market Research. The major driving force for the live vaccines market includes a rise in the prevalence of infectious diseases like yellow fever, polio, measles, and more globally; rising governmental programs; and bolstering healthcare spending capacity of people in both emerging and developed nations. Due to the novel coronavirus outbreak, the live vaccine market is foreseen to witness certain disruptions owing to escalated demands for the launch of relevant vaccines for COVID-19. Gigantic investments are pouring into research and development of a vaccine from both public and private entities globally. These factors are likely to influence the live vaccine market substantially. Even though the cost of vaccination is low, the manufacturing and delivery costs of live vaccines remain relatively high this acts as a key challenge for the manufacturers operating in the live vaccine market.

A live virus vaccine includes live but a weakened version of the virus that is designed to help a human body by building an immune response without the human body developing the symptoms of the disease, the live virus is intended to contain and prevent the ailment. The key use of live vaccines is to introduce the immune system of the human body to the virus, so the body acquires a strong immune response.

The market dynamics covered in the report "Global Live Vaccines Market Report By Type (Viral And Bacterial), By Route Of Administration (Oral, Injection, Intra-Nasal, Combination Of Injection &Oral, Patch, And Inhalation), By Application (Measles, Mumps, Rubella, Varicella, Yellow Fever, Rotavirus, BCG, Vaccinia, Influenza, Typhoid, Oral Polio, Smallpox, Chickenpox, And Others), By Patient (Adults And Pediatric) And By Regions - Industry Trends, Size, Share, Growth, Estimation And Forecast, 2019-2026" gives a holistic scope of the market along with the market forecasts. The contents of the report talks about historic data along with throwing light on the future opportunities of the live vaccines market.

On the basis of Type the live vaccines market is segmented into viral and bacterial. By route of administration the market is divided into oral, injection, intra-nasal, combination of injection &oral, patch, and inhalation. On the basis of application the live vaccines market is segmented into measles, mumps, rubella, varicella, yellow fever, rotavirus, BCG, vaccinia, influenza, typhoid, oral polio, smallpox, chickenpox, and others. By patient the market is divided into adults and pediatric.

North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa are the regions covered in the report. This geographical section of the report highlights the share of the revenue/volume spread globally. 

The Report Segments Global Live Vaccines Market -
By Type

  • Viral
  • Bacterial

By Route of Administration

  • Oral
  • Injection
  • Intra-Nasal
  • Combination of injection &oral
  • Patch
  • Inhalation

By Application

  • Measles
  • Mumps
  • Rubella
  • Varicella
  • Yellow Fever
  • Rotavirus
  • BCG
  • Vaccinia
  • Influenza
  • Typhoid
  • Oral Polio
  • Smallpox
  • Chickenpox
  • Others

By Patient

  • Adults
  • Pediatric

By Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

 
Players Profiled In the Report:
Merck & Co., GlaxoSmithKline plc, Pfizer Inc., Astellas Pharma Inc., Emergent BioSolutions, AstraZeneca plc, Serum Institute of India Pvt. Ltd., Bharat Biotech, Sun Pharmaceutical Industries Limited, and Cipla Limited.

Download the FREE SAMPLE of Global Live Vaccines Market Research Report

 
About Value Market Research -
Value Market Research was established with the vision to ease decision making and empower the strategists by providing them with holistic market information. Our analysts’ team is well equipped with all research tools and techniques and hold deep knowledge of the industry they are working for.

We ensure intellectual, precise and quality data is delivered to our client. We facilitate clients with syndicate research reports and customized research reports on 25+ industries with global as well as regional coverage.

Contact:
Value Market Research
401/402, TFM, Nagras Road, Aundh, Pune-7.
Maharashtra, INDIA.
Tel: +1-888-294-1147
Email: [email protected]
Website: https://www.valuemarketresearch.com

Why Choose Us

Client First Policy
Excellent Quality
Robust After Sales Support
24/7 Email Support

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Clients

Testimonials